skip navigation
OneSign solutions for

life sciences

sign up to stay connected
Gartner’s “Magic Quadrant for Enterprise Single Sign-On 2007,” (Imprivata Positioned in the Leaders Quadrant) - August 2007

"Companies using OneSign benefit not only from secure and reliable SSO, but could also significantly reduce product development costs and implementation time."

Chris Larivee, Senior Software Engineer
Leading Biopharmaceutical Company

Life sciences companies operate in one of the most highly-regulated industries in the world. Now, as pharmaceutical, biotech and medical device manufacturers deal with industry consolidation and the need to compete globally, they are facing a new set of government regulations mandating increased IT security measures and processes – from the Sarbanes-Oxley Act in the U.S to the Data Protection Act in the UK. New industry standards, such as BS7799 in the UK and BS7799-2 and ISO 17799 worldwide, are also driving organizations to adopt stronger security controls. In the case of the government mandates, failure to comply could result in fines and/or legal action.

Compliance has been a challenge for many life sciences companies, primarily due to the high costs, time and resources required to secure complex legacy applications and IT environments. At the same time, many companies have become increasingly concerned about physical security at their facilities. Now, a growing number of pharmaceutical and biotech firms are discovering that Imprivata OneSign solutions offer a practical and affordable means to achieve regulatory compliance while also improving security, reducing IT help desk costs, eliminating password management problems, and improving user productivity.

Imprivata OneSign solutions support the unique requirements of life sciences companies in the following ways:

 

Imprivata OneSign Authentication Management

Imprivata OneSign Single Sign-On

Imprivata Physical/Logical